Repligen Corp. (RGEN)
115.24
-1.71
(-1.46%)
USD |
NASDAQ |
Apr 07, 16:00
115.24
0.00 (0.00%)
After-Hours: 17:17
Repligen SG&A Expense (TTM) : 290.51M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Masimo Corp. | 506.00M |
| Orthofix Medical, Inc. | 554.33M |
| InfuSystem Holdings, Inc. | 67.46M |
| Tandem Diabetes Care, Inc. | 444.99M |
| Plus Therapeutics, Inc. | 12.13M |